Yan Ding
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- RNA modifications and cancer 11
- Epigenetics and DNA Methylation 8
- Circular RNAs in diseases 7
- Ubiquitin and proteasome pathways 6
-
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 9
- Co-authors
- Xin Chen (11 shared papers)Jinbao Liu (10 shared papers)Daolin Tang (10 shared papers)Øystein Fodstad (5 shared papers)Yuhua Zhao (4 shared papers)Ming Tan (5 shared papers)Ming Zhou (3 shared papers)Kangping Cui (9 shared papers)
- Journals
- Journal of Hazardous Materials (4 papers)Frontiers in Oncology (3 papers)Oncotarget (3 papers)Cancer Research (3 papers)Cell Death Discovery (3 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Yan Ding
149 papers receiving 3.5k citations
Yan Ding's Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 909
- Biochemistry 235
- Molecular Biology 1.5k
- Water Science and Technology 226
- Pulmonary and Respiratory Medicine 445
Countries citing papers authored by Yan Ding
This map shows the geographic impact of Yan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ding more than expected).
Fields of papers citing papers by Yan Ding
This network shows the impact of papers produced by Yan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ding. The network helps show where Yan Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Copper-dependent autophagic degradation of GPX4 drives ferroptosis Hit paper breakdown → | 2023 | 459 |
| 2 | 2010 | 348 | |
| 3 | 2009 | 219 | |
| 4 | 2021 | 180 | |
| 5 | H3K18 lactylation of senescent microglia potentiates brain aging and Alzheimer's disease through the NFκB signaling pathway Hit paper breakdown → | 2023 | 151 |
| 6 | 2013 | 111 | |
| 7 | 2012 | 93 | |
| 8 | 2020 | 89 | |
| 9 | 2019 | 87 | |
| 10 | 2015 | 60 | |
| 11 | 2023 | 59 | |
| 12 | 2012 | 59 | |
| 13 | 2005 | 55 | |
| 14 | 2023 | 52 | |
| 15 | 2013 | 49 | |
| 16 | 2021 | 46 | |
| 17 | 2022 | 45 | |
| 18 | 2014 | 43 | |
| 19 | 2019 | 40 | |
| 20 | 2018 | 38 |
About Yan Ding
Yan Ding is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Epidemiology, having authored 165 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (11 papers), Autophagy in Disease and Therapy (9 papers), MicroRNA in disease regulation (9 papers), Epigenetics and DNA Methylation (8 papers), Circular RNAs in diseases (7 papers), Ubiquitin and proteasome pathways (6 papers) and Ferroptosis and cancer prognosis (6 papers). The work is most often cited by research in Cancer Research (909 citations), Biochemistry (235 citations), Molecular Biology (1.5k citations), Water Science and Technology (226 citations) and Pulmonary and Respiratory Medicine (445 citations). Yan Ding has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Xin Chen, Jinbao Liu, Daolin Tang, Øystein Fodstad, Yuhua Zhao, Ming Tan, Ming Zhou, Kangping Cui, Yihan Chen and Minshu Cui. Their work appears in journals such as Journal of Hazardous Materials, Frontiers in Oncology, Oncotarget, Cancer Research and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.